Top compounds associated with response to ZNF84


Feature Type Standardized
Nominal ANOVA
mRNA AR-42 GDSC1000 pan-cancer AAC 0.2 3e-10
mRNA I-BET-762 GDSC1000 pan-cancer AAC 0.18 4e-10
mRNA navitoclax:piperlongumine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.23 5e-10
mRNA pac-1 CTRPv2 pan-cancer AAC 0.23 7e-10
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.21 8e-10
mRNA BRD-A02303741:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.22 1e-09
mRNA ABT-199 CTRPv2 pan-cancer AAC 0.26 1e-09
mRNA PIK-93 GDSC1000 pan-cancer AAC 0.18 2e-09
mRNA tubastatin A GDSC1000 pan-cancer AAC 0.19 2e-09
mRNA YM201636 GDSC1000 pan-cancer AAC 0.19 2e-09
Download CSV